Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H28N8 |
| Molecular Weight | 416.522 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=NN(CC2=CN=C(C=C2)C3=CC=CC=C3C4=NN=NN4)C(CCCC)=N1
InChI
InChIKey=YONOBYIBNBCDSJ-UHFFFAOYSA-N
InChI=1S/C23H28N8/c1-3-5-11-21-25-22(12-6-4-2)31(28-21)16-17-13-14-20(24-15-17)18-9-7-8-10-19(18)23-26-29-30-27-23/h7-10,13-15H,3-6,11-12,16H2,1-2H3,(H,26,27,29,30)
Forasartan (also known as SC-52458) was developed as an orally active, competitive angiotensin (Ang) II subtype 1 (AT1)-receptor antagonist for the treatment of hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. It is known that angiotensin II is a vasoconstrictor and stimulates the synthesis and release of aldosterone, and blockage of its effects results in a decrease in systemic vascular resistance. Information about the further development of forasartan is not available.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Bee (Apis mellifera, Hymenoptera: Apoidea) visitation to cantaloupe Cucumis melo (Cucurvitaceae) flowers in Panama]. | 2007-06 |
|
| Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification. | 2003-02-27 |
|
| Inositol(1,4,5)trisphosphate signal triggers a receptor-mediated ATP release. | 2002-05-03 |
|
| Possible involvement of calcium-calmodulin pathways in the positive chronotropic response to angiotensin II on the canine cardiac sympathetic ganglia. | 2001-08 |
|
| Upregulation of immunoreactive angiotensin II release and angiotensinogen mRNA expression by high-frequency preganglionic stimulation at the canine cardiac sympathetic ganglia. | 2001-01-19 |
|
| Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629. | 1995-01 |
|
| Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist. | 1993-10 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9156352
two groups of eight healthy men ingested placebo or increasing single oral doses (10, 25, and 50 mg or 100, 150, and 200 mg) of SC-52458 (FORASARTAN).
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66930
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
145216-43-9
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
132706
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
DB01342
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
141552
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
100000080432
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
7415
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
CHEMBL315021
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
6896
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
Forasartan
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
SUB07781MIG
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
C65749
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
C084927
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
065F7WPT0B
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
GG-68
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY | |||
|
DTXSID70162942
Created by
admin on Mon Mar 31 18:08:45 GMT 2025 , Edited by admin on Mon Mar 31 18:08:45 GMT 2025
|
PRIMARY |
ACTIVE MOIETY